Nov 17, 2020
Personnel Changes
TOKYO, November 17, 2020 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced the following personnel changes effective January 1, 2021.
[Details of Personnel Changes]
Effective January 1, 2021
Executive officers
| Name | New Responsibilities | Current Responsibilities |
|---|---|---|
| Hisafumi Okabe | Executive Vice President Supervisory responsibility for Research and Translational Research |
Executive Vice President Supervisory responsibility for Research and Translational Research Head of Translational Research Div. |
| Yoshiaki Ohashi | Senior Vice President Special Mission for CEO |
Senior Vice President Head of Quality & Regulatory Compliance Unit and Head of Drug Safety Div. |
| Tetsuya Yamaguchi | Senior Vice President Head of Project & Lifecycle Management Unit In charge of Corporate Planning Dept. |
Senior Vice President Head of Corporate Planning Dept. and Head of Foundation Medicine Unit |
| Minoru Watanabe | Vice President Head of Drug Safety Div. and Head of Foundation Medicine Unit |
Vice President Head of Project & Lifecycle Management Unit |
| Hiroshi Murata | Vice President Special Mission for CEO |
Vice President Head of Pharmaceutical Technology Div. |
| Junichi Nezu | Vice President Head of R&D Portfolio Management Dept., Project & Lifecycle Management Unit |
Vice President Head of Research Div. |
| Masatoshi Takada | Vice President Marketing & Sales Div. |
Vice President Head of Kansai Regional Management Office, Marketing & Sales Div. |
Please see the PDF file about other personnel changes.
